Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 in the Treatment of Pancreatic Cancer With Liver Metastasis
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Summary
1. Clinical evaluation of multimodal ablation system for pancreatic cancer with hepatic metastatic malignancies. 2. Construction of a combined treatment system of multimodal ablation therapy combined with immunotherapy and chemotherapy. 3. Transformation and clinical application of multimodal ablation system for pancreatic cancer with hepatic metastatic malignancies.
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2023-10-08
Completion Date
2026-12-31
Last Updated
2025-07-09
Healthy Volunteers
No
Conditions
Interventions
Multi-mode thermal ablation device
The tumor tissue was rapidly frozen until the ice ball exceeded 5mm of the lesion tissue, kept for 5 minutes, then thawed and warmed. Then, complete ablation was performed according to the radiofrequency temperature control mode of multimodal tumor therapy to ensure that the ablation area included a safe range of 5\~10mm around the tumor.
Intravenous anti-PD-1 and chemotherapy
intravenous anti-PD-1 and chemotherapy
Locations (1)
Shanghai General Hospital
Shanghai, Shanghai Municipality, China